Skip to main content

Performance evaluation of Elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available ELISA assays in rheumatoid arthritis diagnosis.

Cai B, Wang L, Liu J, Feng W

Publication: Clin Biochem (2011) • Vol 44 • Page 989-93PMID: 21640094View on PubMed

Purpose

The purpose of this paper was to compare detection of anti-cyclic citrullinated peptide (anti-CCP) with the Elecsys analyzer and two ELISA methods and determine the effects on the diagnosis of rheumatoid arthritis (RA).

Conclusion

Anti-CCP levels were higher in RA patients than in other patients or healthy individuals. The diagnostic accuracy for RA of the three methods was similar, but anti-CCP was higher when measured using the Euro-diagnostica ELISA and the Elecsys analyzer than with the Euroimmun ELISA. The sensitivity for anti-CCP detection was highest using the Elecsys assay and the specificity was greatest using the Elecsys assay or the Euro-diagnostica ELISA. The authors defined new optimal cut-off values which improved the sensitivity and specificity of the Elecsys assay, but did not improve sensitivity of the other methods.

Studies (1)

Purpose

The purpose of this study was to determine the effects of detection method on the measurement of anti-CCP in patients with RA, other autoimmune diseases, involution diseases, and in healthy controls.

Summary of Findings

Anti-CCP levels were higher in RA patients than in normal controls or non-RA patients (p< 0.05). The diagnostic accuracy for RA of the Euroimmun ELISA, Euro-diagnostica ELISA, and the Elecsys analyzer were and 76.39%, 77.08% and 77.78% respectively. Anti-CCP levels were higher when measured using the Euro-diagnostica ELISA or the Elecsys analyzer than with the Euroimmun ELISA. There was no correlation of anti-CCP with CRP levels. One of 9 patients with osteoarthritis and 1 of 2 with scleroderma tested positive for anti-CCP using all three assays, and 1 of 4 patients with polymyositis tested positive using the Euroimmun ELISA. There was no significant effect of assay type on the area under the specificity versus sensitivity plots. Using the manufacturers cut-off values, the sensitivity for anti-CCP detection was highest using the Elecsys assay (67.74%) and the specificity was greatest using the Elecsys assay or the Euro-diagnostica ELISA (both 92.86%). Use of the optimal cut-off values for each assay increased the specificity but sensitivity was only increased for the Elecsys assay.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Lupus
    Normal
    Osteoarthritis
    Rheumatoid Arthritis
    Other diagnoses
    Osteoporosis
  • Platforms

    ProteinELISA
    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Ankylosing spondylitis
    Osteochondritis
    Polymyositis
    Scleroderma
    Systemic sclerosis
    ELISA SpecificTargeted peptide/protein
    CRP
    anti-CCP
    Clinical chemistry/auto analyzer SpecificTechnology platform
    Euro-diagnostica ELISA
    Euroimmun ELISA